Response to “Comment on: ‘When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council’” - 16/07/18
Funding sources: Corporate sponsorship was provided to the International Eczema Council by Abbvie, Amgen, Celgene, Chugai, Galderma, Glaxo-SmithKline/Stiefel, the Leo Foundation, Leo Pharma, Lilly, MedImmune/Astrazeneca, Pfizer, Sanofi, Genzyme and Regeneron Pharmaceuticals, and Valeant. The cost of publication was covered by the International Eczema Council. |
|
Disclosure: Dr Simpson is an investigator for Eli Lilly and Company, Leo, AbbVie, GlaxoSmithKline, Regeneron, Novartis, Vanda, and Tioga and a consultant with honorarium for Eli Lilly and Company, Celgene, Dermira, Leo, AbbVie, Glaxo Smith Kline, Pfizer, Regeneron, and Menlo Therapeutics. Dr Reynolds is an investigator for Biotechnology and Biological Sciences Research Council Case with Stiefel/GSK, Innovate UK and Stiefel/GSK, Genentech, Biotechnology and Biological Sciences Research Council Case with AstraZeneca, and Bristol-Myers Squibb and a consultant with honorarium for Genentech. Dr Flohr is a consultant with honorarium for Sanofi and Genentech. Dr Paller is an investigator for Galderma, Leo Foundation, Leo Pharmaceuticals, Incyte Corporation, and Regeneron-Sanofi and a consultant with honorarium for AbbVie, Dermira, Eli Lilly and Company, Expanscience, GSK-Stiefel, Menlo Therapeutics, Novartis, Pfizer, Sanofi-Regeneron, and Valeant. Dr Cork is an investigator for Leo, Sanofi, and Regeneron, and he has received a symposium grant from Sanofi and served as a consultant with honorarium for Regeneron, Sanofi, Novartis, and L'Oreal. Dr Guttman-Yassky is an investigator for Celgene, Dermira, Glenmark, Pfizer, Janssen Biotech, Novartis, DBV/Innovaderm, Leo Pharma, Merck Pharma, Regeneron, BMS, Immune, Eli Lilly and Company, MedImmune, Vitae, UCB, Galderma, AbbVie, Asana, Sienna, Regeneron, AntibioTx/Innovaderm, and Novan and a consultant with honorarium for Allergan, Escalier, SunPharma, Arena, AbbVie, Anacor, Celgene, Pfizer, Regeneron, Sanofi, Dermira, GlaxoSmithKline, Vitae, Eli Lilly and Company, BMS, Galderma, Genentech, Glenmark, Leo Pharma, and Novartis. Dr Irvine is a consultant with honorarium for Sanofi Regeneron, AbbVie, Genentech, Anacor, and Chugai Pharma. Dr Silverberg has no conflicts of interest to disclose. |
|
The sponsors had no influence on the content and viewpoints in this article. |
Vol 79 - N° 2
P. e25-e26 - août 2018 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?